1. Medtech Insight
  2. >>Business

Stryker M&A Strategy Intact Under New CEO With Latest Deal For Stroke Care

Purchase of Surpass Medical for $135 million represents Stryker’s 10th acquisition since 2009. The company affirmed its acquisition strategy focused on core and key adjacent markets during its Oct. 17 earnings call, but also sought to ratchet down earnings growth expectations in the near term to account for headwinds, including the upcoming U.S. medical device excise tax.

Stryker’s newly appointed CEO Kevin Lobo has affirmed the company’s acquisition strategy focused on core and key adjacent markets with the $135 million purchase of aneurysm device maker Surpass Medical, announced Oct. 16.

During the firm’s third-quarter earnings call the next day, Lobo’s first since taking over as CEO Oct. 1, the exec said Stryker will continue to focus on key areas such...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business